These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21266169)

  • 21. Hepatitis B virus transfusion risk in China: proficiency testing for the detection of hepatitis B surface antigen.
    Zhang R; Wang L; Li J
    Transfus Med; 2010 Oct; 20(5):322-8. PubMed ID: 20409073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Selecting methods of controls concentration for internal quality control and continuity of control chart between different reagent lots for HBsAg qualitative detection].
    Li JM; Zheng HJ; Wang LN; Deng W
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):228-31. PubMed ID: 12716523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of nine different qualitative HBsAg assay kits].
    Yang J; Kim JH; Kim Y
    Korean J Lab Med; 2010 Apr; 30(2):178-84. PubMed ID: 20445337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparison study with enzyme immunoassay and chemiluminescence immunoassay for hepatitis B virus surface antigen detection].
    Huh HJ; Chae SL; Cha YJ
    Korean J Lab Med; 2007 Oct; 27(5):355-9. PubMed ID: 18094601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An evaluation of the sensitivity of commercial ELISA kits for the detection of HBsAg].
    Babeş VT; Badea D; Picior M
    Rev Roum Virol; 1991; 42(3-4):135-9. PubMed ID: 1814430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application Study of Neutralization Confirmatory Testing for Low Positive Hepatitis B Surface Antigen.
    Han H; Huang YH; Dong Q; Lu JQ; Chen K
    Clin Lab; 2024 Sep; 70(9):. PubMed ID: 39257125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new HBsAg screening assay designed for sensitive detection of HBsAg subtypes and variants.
    van Roosmalen MH; de Jong JJ; Haenen W; Jacobs T; Couwenberg F; Ahlers-de Boer GJ; Hellings JA
    Intervirology; 2006; 49(3):127-32. PubMed ID: 16428888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of hybridoma cell lines producing monoclonal antibodies against hepatitis B virus surface antigens (a, d, and r) and development of sensitive ELISA diagnostic test.
    Tang X; Zhang X; Xu H
    Hybridoma; 2001 Feb; 20(1):47-52. PubMed ID: 11289227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the test results on hepatitis B pilot surveillance labortory in 9 provinces of China].
    Wang FZ; Cui FQ; Gong XH
    Zhongguo Yi Miao He Mian Yi; 2010 Jun; 16(3):203-6, 274. PubMed ID: 20726257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection.
    Scheiblauer H; Soboll H; Nick S
    J Med Virol; 2006; 78 Suppl 1():S66-70. PubMed ID: 16622881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brief communication: comparison the diagnostic performance of four HBsAg ELISA kits.
    Wan-zhou X; Yan L; Qing W; Ming W; Ze-gang W
    J Clin Lab Anal; 2013 Jul; 27(4):294-6. PubMed ID: 23852787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of hepatitis B virus markers using a biosensor based on imaging ellipsometry.
    Qi C; Zhu W; Niu Y; Zhang HG; Zhu GY; Meng YH; Chen S; Jin G
    J Viral Hepat; 2009 Nov; 16(11):822-32. PubMed ID: 19486471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactivity of genotypically distinct hepatitis B virus surface antigens in 10 commercial diagnostic kits available in Japan.
    Mizuochi T; Okada Y; Umemori K; Mizusawa S; Sato S; Yamaguchi K
    Jpn J Infect Dis; 2005 Apr; 58(2):83-7. PubMed ID: 15858285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors?
    Busch MP
    Transfus Clin Biol; 2004 Feb; 11(1):26-32. PubMed ID: 14980546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negative interference in serum HBsAg ELISA from rheumatoid factors.
    Xu L; Yu Z; Fan W; Wang X; Xie M; Xu Y; Hu L; Li Y
    PLoS One; 2013; 8(11):e80620. PubMed ID: 24260439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validity of the rapid strip assay test for detecting HBsAg in patients admitted to hospital in Uganda.
    Seremba E; Ocama P; Opio CK; Kagimu M; Yuan HJ; Attar N; Thomas DL; Lee WM
    J Med Virol; 2010 Aug; 82(8):1334-40. PubMed ID: 20572076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developing a double-antigen sandwich ELISA for effective detection of human hepatitis B core antibody.
    Deng LJ; Xu Y; Huang J
    Comp Immunol Microbiol Infect Dis; 2008 Nov; 31(6):515-26. PubMed ID: 18242704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the technical and clinical performance of the Elecsys HBsAg II assay with the Architect, AxSym, and Advia Centaur HBsAg screening assays.
    Louisirirotchanakul S; Khupulsup K; Akraekthalin S; Chan KP; Saw S; Aw TC; Cho DH; Shin MG; Lim J
    J Med Virol; 2010 May; 82(5):755-62. PubMed ID: 20336717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European collaborative evaluation of the Enzygnost HBsAg 6.0 assay: performance on hepatitis B virus surface antigen variants.
    Avellón A; Echevarría JM; Weber B; Weik M; Schobel U; Willems WR; Gerlich WH
    J Med Virol; 2011 Jan; 83(1):95-100. PubMed ID: 21108344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.